masthead_squiggle
released publications

Resources

envelope

publications

First-in-class trispecific VHH-Fc based antibody with potent prophylactic and therapeutic efficacy against SARS-CoV-2 and variants

03/2022 Journal: Clinica Chimica Author: Titong, A., Gallolu Kankanamalage, S., Dong, J. et al.

envelope

publications

A thin-film interferometry-based label-free immunoassay for the detection of daratumumab interference in serum protein electrophoresis

12/2019 Journal: Clinica Chimica Author: Ruben Luo

envelope

publications

Development of multi-specific humanized llama antibodies blocking SARS-CoV-2/ACE2 interaction with high affinity and avidity

05/2020 Journal: Emerging Microbes & Infections Author: Jianbo Dong

envelope

publications

Development of Label-Free Immunoassays as Novel Solutions for the measurement of monoclonal antibody drugs and antidrug antibodies

07/2020 Journal: Clinical Chemistry Author: Ruben Luo

envelope

publications

Kinetics of SARS-CoV-2 Antibody Avidity maturation and association with disease severity

09/2020 Journal: Clinical Infectious Diseases Author: Ruben Luo

envelope

publications

Selection and characterization of an ssDNA aptamer against thyroglobulin

09/2020 Journal: Talanta Author: Chao Zhu

envelope

publications

A potent SARS-CoV-2 neutralizing human monoclonal antibody that reduces viral burden and disease severity in Syrian hamsters

09/2020 Journal: Frontiers in Immunology Author: Anna C. Fagre

envelope

publications

Development of humanized tri-specific nanobodies with potent neutralization for SARS-CoV-2

10/2020 Journal: Scientific Reports Author: Jianbo Dong

envelope

publications

A SARS-CoV-2 Label-Free Surrogate Virus Neutralization Test and a Longitudinal Study of Antibody Characteristics in COVID-19 Patients

04/2021 Journal: JCM Author: Ruben Luo

envelope

publications

TOP-Plus is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability

09/2021 Journal: Clinical Chemistry Author: Sabrina & Zhen

envelope

publications

Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients

05/2021 Journal: Emerging Microbes & Infections Author: Qihong Yan

envelope

publications

Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients

05/2021 Journal: Virologica Sinica Author: Jiangfan Li